Ledger.Open graph →
SEC Form D · filed November 12, 2015

Miragen Therapeutics, Inc

Offering
$41.1M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boulder, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

William S. Marshall · Boulder, COExec · DirectorKyle H. Lefkoff · Boulder, CODirectorJason A. Leverone · Boulder, COExecThomas E. Hughes · Boulder, CODirectorBruce L. Booth · Boulder, COExec · DirectorMarvin H. Caruthers · Boulder, CODirectorJohn E. Creecy · Boulder, CODirectorJames M. Brady · Great Falls, VAExec · DirectorJames E. Dickinson · PORTLAND, ORDirectorJoanne M. Lipman · Great Falls, VAExec · DirectorRichard J. Walters Ii · EAST PETERSBURG, PAExecJoan M. Brady · Great Falls, VADirectorDavid J. Rodman · Boulder, COExecJoshua E. Resnick · Boulder, CODirectorChristopher J. Morl · Boulder, COExecAnthony B. Lennen · Indianapolis, INDirectorReuven Dessler · Solon, OHDirectorJoel Goldman · Solon, OHExec · DirectorVincent Deruelle · New York, NYExecBenoit Buridant · New York, NYExec · DirectorMarvin H. Caruthers · Boulder, CODirectorDavid J. Rodman · Boulder, COExecJoshua E. Resnick · Boulder, CODirectorJohn E. Creecy · Boulder, CODirectorChristopher J. Morl · Boulder, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗